Kapstone Financial Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Buy
5,719
+73
+1% +$15.2K 0.57% 37
2026
Q1
$1.19M Hold
5,646
0.58% 35
2025
Q4
$1.16M Buy
5,646
+245
+5% +$46.1K 0.58% 32
2025
Q3
$848K Hold
5,401
0.4% 37
2025
Q2
$907K Buy
5,401
+595
+12% +$88.3K 0.45% 35
2025
Q1
$662K Hold
4,806
0.37% 41
2024
Q4
$614K Buy
4,806
+160
+3% +$18.7K 0.33% 51
2024
Q3
$510K Hold
4,646
0.31% 61
2024
Q2
$457K Buy
4,646
+230
+5% +$23.4K 0.3% 59
2024
Q1
$494K Buy
4,416
+50
+1% +$5.39K 0.34% 56
2023
Q4
$462K Buy
4,366
+195
+5% +$19.3K 0.36% 54
2023
Q3
$362K Buy
4,171
+213
+5% +$19.3K 0.33% 60
2023
Q2
$363K Hold
3,958
0.3% 65
2023
Q1
$319K Buy
3,958
+400
+11% +$30.2K 0.29% 68
2022
Q4
$271K Buy
+3,558
New +$270K 0.25% 78

Other funds holding CAH

Kapstone Financial Advisors's CAH Position: Q2 2026 in Review

Kapstone Financial Advisors increased its Cardinal Health (CAH) stake by 1.3% in Q2 2026, buying an estimated $15.2K and bringing the position to 5,719 shares worth $1.36M. The position accounts for 0.57% of the portfolio, ranked #37.

Kapstone Financial Advisors first reported a position in CAH in Q4 2022 and has held it in 15 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Kapstone Financial Advisors held 5,719 shares of Cardinal Health worth $1.36M as of Q2 2026.
  • Kapstone Financial Advisors bought 73 Cardinal Health shares in Q2 2026, an estimated $15.2K.
  • Cardinal Health made up 0.57% of Kapstone Financial Advisors's portfolio in Q2 2026, its #37 holding.
  • Kapstone Financial Advisors first reported a position in Cardinal Health in Q4 2022 and has held it in 15 quarters since.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Kapstone Financial Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.